Announced Thu, 13 Nov · 14:45 IST

Newspaper Publication of unaudited Financial Results (Consolidated and Standalone) for the Quarter and Half Year Ended September 30, 2025

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Pharmaids Pharmaceuticals has submitted copies of newspaper advertisements containing its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The ads were published on November 13, 2025 in the English daily 'Financial Express' and the Kannada vernacular 'Hosa Digantha'. This filing is made under Regulation 30 and 47 of SEBI's Listing Obligations and Disclosure Requirements, 2015. The actual financial numbers in the submitted text are not clearly readable due to image/OCR quality, so specific revenue or profit figures cannot be confirmed from this document. The company is registered in Bangalore with BSE scrip code 524572.

Likely market impact

This is a routine regulatory compliance disclosure — the newspaper publication is a follow-up formality after the results were already filed with the stock exchange. No new financial information is being revealed here, so it should have no direct impact on the share price.